Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
102.00    0.20 (0.20%)
Bid:
102.40
Ask:
102.80
Spread: 0.40 (0.391%)
Market Cap: £167.22m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Interim Management Statement

6 May 2010 11:00

RNS Number : 4369L
Yule Catto & Co PLC
06 May 2010
 



6 May 2010

 

Yule Catto & Co plc 

 

Interim Management Statement

 

Yule Catto & Co plc, the international producer of speciality chemicals, today issues its Interim Management Statement for the period from 1 January to 31 March 2010

 

 

The Group has made a good start to the year with first quarter PBT comfortably ahead of last year.

 

Polymer Chemicals is the Group's main business, accounting for 88% of divisional operating profit in 2009 with 50% of its revenue in Asia and emerging markets. The business made a good start to the year. Volumes were over 10% up on prior year, strongly ahead of the weak first quarter of 2009. Volumes in Asia remain strong. Whilst Europe started slowly, in part due to the difficult weather conditions, demand strengthened through the quarter and this has continued into April. Monomer prices continued to rise through the quarter and the business has continued to seek to recover these increases in the market place.

 

Pharma Chemicals has continued to trade weakly, with profits in the first quarter below prior year, though the business has a good current forward order book.

 

William Blythe, the remaining Impact Chemicals business was ahead of last year as expected.

 

Net debt rose during the quarter, as the improving demand position absorbed additional working capital, but is still comfortably below £100 million. We are still in the process of completing the announced sale of the Finewaters adhesive business, which will deliver a further reduction in debt of £11 million when concluded.

 

Looking forward in Polymers we expect to see continuing strong demand in Asia and modest volume improvement in Europe. Monomer prices have continued to rise during the second quarter and work is in hand to recover these increases. Pharma, after the slow start, is likely to trade a little below last year, whilst William Blythe will be ahead. Overall trading is in line with the Board's previous expectations for the full year.

 

 

ENQUIRIES:

 

YULE CATTO & Co plc

Tel: 01279 442791

Adrian Whitfield, Chief Executive

David Blackwood, Finance Director

HOGARTH

Tel: 020 7357 9477

John Olsen

Andrew Jaques

Ian Payne

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSLIFLTEFIRIII
Date   Source Headline
6th May 201011:00 amRNSInterim Management Statement
30th Apr 201012:40 pmRNSAnnual Information Update
8th Apr 20107:00 amRNSAnnual Financial Report
12th Mar 20107:00 amRNSDisposal
11th Mar 201010:32 amRNSDirector/PDMR Shareholding
11th Mar 201010:31 amRNSDirector/PDMR Shareholding
10th Mar 20107:00 amRNSFinal Results
11th Feb 201012:32 pmRNSHolding(s) in Company
4th Feb 201011:38 amRNSHolding(s) in Company
12th Jan 20107:00 amRNSTrading Update
25th Nov 200910:02 amRNSHolding(s) in Company
18th Nov 20099:28 amRNSHolding(s) in Company
19th Oct 20097:00 amRNSInterim Management Statement
2nd Sep 200910:14 amRNSHolding(s) in Company
24th Aug 20097:00 amRNSHalf Yearly Report
23rd Jun 20097:00 amRNSPre-close Trading Update
18th May 20099:16 amRNSDirector/PDMR Shareholding
14th May 200912:40 pmRNSResult of AGM
14th May 20097:00 amRNSAGM & Interim Management Statement
1st May 20097:00 amRNSAppointment of new joint brokers
21st Apr 20094:20 pmRNSAnnual Information Update
15th Apr 20099:24 amRNSAnnual Financial Report
23rd Mar 20094:03 pmRNSHolding(s) in Company
23rd Mar 20094:01 pmRNSHolding(s) in Company
20th Mar 200910:31 amRNSDirector/PDMR Shareholding
19th Mar 20097:00 amRNSAppointment of Senior Independent Director
16th Mar 20094:54 pmRNSDirector/PDMR Shareholding
12th Mar 20092:35 pmRNSDirector/PDMR Shareholding
12th Mar 20092:31 pmRNSDirector/PDMR Shareholding
11th Mar 20094:18 pmRNSDirector/PDMR Shareholding
11th Mar 20097:00 amRNSFinal Results
4th Mar 20094:35 pmRNSPrice Monitoring Extension
4th Mar 20091:57 pmRNSAppointment of non-executive director
13th Feb 20094:40 pmRNSSecond Price Monitoring Extn
13th Feb 20094:35 pmRNSPrice Monitoring Extension
30th Jan 20093:54 pmRNSNew Loan Facility / Completion of Disposal
21st Jan 20097:00 amRNSAppointment of new Chairman
19th Jan 20094:29 pmRNSDirector/PDMR Shareholding
15th Jan 20091:59 pmRNSDirector/PDMR Shareholding
13th Jan 200912:33 pmRNSHolding(s) in Company
7th Jan 20095:29 pmRNSDirector/PDMR Shareholding
5th Jan 200911:17 amRNSDisposal
29th Dec 20087:00 amRNSUpdate
12th Dec 200810:08 amRNSHolding(s) in Company
4th Dec 20087:00 amRNSSale of PFW Aroma Chemicals BV
3rd Dec 200810:57 amRNSBlocklisting Interim Review
20th Nov 20084:47 pmRNSSecond Price Monitoring Extn
20th Nov 20084:39 pmRNSPrice Monitoring Extension
14th Nov 20087:00 amRNSInterim Management Statement
10th Nov 20083:04 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.